Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 0 | 0 | 0 | 646 | 1,301 |
| Gross Profit | N/A | N/A | N/A | 646 | 1,301 |
| Operating Expenses | 74,561 | 54,457 | 23,831 | 11,708 | 11,235 |
| Operating Income | -74,561 | -54,457 | -23,831 | -11,062 | -9,934 |
| Interest Expense | 887 | 828 | 605 | 373 | 2 |
| Other Income | -919 | 2 | 6 | 0 | 2,740 |
| Pre-tax Income | -76,367 | -55,283 | -24,430 | -11,435 | -7,196 |
| Net Income Continuous | -76,367 | -55,283 | -24,430 | -11,435 | -7,196 |
| Net Income Discontinuous | N/A | N/A | 1,082 | -379 | -150 |
| Net Income | $-76,367 | $-55,283 | $-23,348 | $-11,814 | $-7,346 |
| EPS Basic Total Ops | -2.87 | -3.42 | -1.91 | -1.96 | -3.80 |
| EPS Basic Continuous Ops | -2.87 | -3.42 | -2.00 | -1.90 | -3.60 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.09 | -0.06 | -0.08 |
| EPS Diluted Total Ops | -2.87 | -3.42 | -1.91 | -1.96 | -3.80 |
| EPS Diluted Continuous Ops | -2.87 | -3.42 | -2.00 | -1.90 | -3.60 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.09 | -0.06 | -0.08 |
| EBITDA(a) | $-73,410 | $-53,591 | $-23,245 | $-10,780 | $-9,707 |